SEC Form 4 · accession 0001104659-15-052504
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Michael Cashman
Officer — President and CEO · Director
Period of report
Jul 20, 2015
Accepted (ET)
Jul 22, 2015 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $14.30 | Jul 20, 2015 | A | 160,000 | A | — | Jul 20, 2025 | Common Stock | 160,000 | 160,000 | D |
Explanation of responses
- F1Options to purchase shares vest in 36 equal monthly installments commencing 08/01/2015.